Multiple Myeloma: Comparing Treatment Approaches

We are studying two treatment plans for newly diagnosed multiple myeloma patients who cannot have a transplant. Our goal is to see which plan helps more patients reach a state of minimal disease.

11-15 visits Confirmation phase (III)No Placebo Cost Reimbursement Standard Medicines Oral InjectionHematologyOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Darzalex

Darzalex is a medicine used to treat multiple myeloma, a type of blood cancer.

Dexamethason Cf

Dexamethason Cf is a steroid medicine used to reduce inflammation and treat allergic reactions and other immune-related conditions.

Dexamethason Teva

Dexamethason Teva is a steroid medicine used to reduce inflammation and calm the immune system for allergies, asthma, and other inflammatory conditions.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Daratumumab

Daratumumab is a substance that helps treat multiple myeloma, a blood cancer, by directing the immune system to attack the cancerous plasma cells.

Dexamethasone

Dexamethasone is a steroid that reduces inflammation and suppresses the immune system to treat allergic, inflammatory, and autoimmune conditions.

Lenalidomide

Lenalidomide is a substance that helps treat certain blood cancers by affecting the immune system to stop cancer growth.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

7,5 Mg Stada

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Ordensklinikum Linz GmbH

040001: Elisabethinen - Hämatologie, Hämostaseologie, medizinische Onkologie

Linz, Austria

SCRI CCCIT Ges.m.b.H.

040002: NA

Salzburg, Austria

Stadt Wien Wiener Gesundheitsverbund

040003: Klinik Ottakring, 1. Medizinische Abteilung

Vienna, Austria

Sponsor: European Myeloma Network B.V.

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.